AMYPAD to be presented at #30AEC
Our project leader Gill Farrar will be presenting AMYPAD at the Alzheimer Europe Conference (#30AEC) as part of the Neuronet session entitled “Regulatory & HTA assessment: a critical step in delivering innovation for patient benefit”.
The conference will be hosted online from 20 to 22 October 2020, under the banner “Dementia in a Changing World”. Online registration is open until 19 October 2020. Information on conference registrations and a link to the conference registration portal can be found HERE.
The session “Regulatory and HTA assessment: a critical step in delivering innovation for patient benefit” will be held on 21 October at 14:15-15:30 CET. This P15 session includes four talks:
- A framework for regulatory and health technology assessment engagement in neurodegenerative disease research ( – , )
- ROADMAP: regulatory and health technology assessment considerations for new Alzheimer’s disease drugs (J – , )
- AMYPAD: Lessons and reflections from Regulatory and HTA Interactions – , )
- The Mobilise-D consortium regulatory strategy for qualification of wearable sensors to quantify mobility in drug trials – , )
More News
